Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

PELP1 inhibition by SMIP34 reduces endometrial cancer progression via attenuation of ribosomal biogenesis

Molecular Oncology(2023)10.1002/1878-0261.13539Source: DataRank Database

PELP1 inhibition by SMIP34 reduces endometrial cancer progression via attenuation of ribosomal biogenesis is a research paper published in Molecular Oncology (2023). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

Linked data & code

geo cellosaurus hpa pdb

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (26 grants)Impact (FWCI 0.46)OA: goldTopics (58)IDs (PubMed, PMC, OpenAlex)Annotations (4)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (17)

Zexuan Liu ORCID,Weiwei Tang ORCID,Uday P. Pratap ORCID,Alexia B. Collier,Kristin A. Altwegg ORCID

Live enrichment

PubMed:37853941 PMC:PMC11467795 OpenAlex:https://openalex.org/W4387765167

National Cancer Institute

Grant: F31‐CA257298

National Cancer Institute

Grant: R01CA267893‐01A1

NIH Office of the Director

Grant: RO1CA267893

U.S. Department of Veterans Affairs

Grant: 101 BX004545‐01

National Institute of General Medical Sciences

Grant: R25GM130437

Cancer Prevention and Research Institute of Texas

Grant: RP210208

Cancer Prevention and Research Institute of Texas

Grant: RP160732

National Institutes of Health

Grant: P30CA054174

NCI NIH HHS

Grant: F31-CA257298

NCI NIH HHS

Grant: R50 CA265339

Mays Cancer Center Support Grant

Grant: P30CA054174-17

NCI NIH HHS

Grant: R01CA267893-01A1

NIH Shared Instrument Grant

Grant: 1S10OD021805-01

High Throughput DNA Sequencer: Illumina HiSeq 3000 Sequencer

BLRD VA

Grant: I01 BX004545

CPRIT Research Training Award

Grant: RP170345RP160

NIH HHS

Grant: S10 OD021805

NIH HHS

Grant: S10 OD030311

NCI NIH HHS

Grant: F31 CA257298

NCI NIH HHS

Grant: R01 CA267893

Grant: 101 BX004545-01

National Institutes of Health

Grant: 1R50CA265339-01A1

Advancing Cancer Research Through Next Generation Sequencing at Mays Cancer Center of UT Health San Antonio

National Institutes of Health

Grant: 3R25GM130437-02S1

Improving data collection infrastructure to enhance evaluation capacity of graduate school

National Institutes of Health

Grant: 5F31CA257298-02

Development of Small Molecule Inhibitor of PELP1 for Treating Advanced Breast Cancer

National Institutes of Health

Grant: 1S10OD030311-01

Illumina NovaSeq 6000 Sequencing System

National Institutes of Health

Grant: 5P30CA054174-16

SAN ANTONIO CANCER INSTITUTE

National Institutes of Health

Grant: 4R01CA267893-04

Development of new therapeutic approaches for endometrial cancer

FWCI

0.46

Citation Percentile

0.6%

Citation Trend

2024

2025

goldLicense: cc-by

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1878-0261.13539

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/1878-0261.13539

publisherhttps://febs.onlinelibrary.wiley.com/doi/pdf/10.1002/1878-0261.13539

journalhttps://doi.org/10.1002/1878-0261.13539

repositoryhttps://pubmed.ncbi.nlm.nih.gov/37853941

Fields of Study

RNA modifications and cancerRNA Research and SplicingRNA and protein synthesis mechanisms0303 health sciences03 medical and health sciences

MeSH Terms

AnimalsCell SurvivalFemaleHumansPeptidesRibosomesTranscription FactorsEndometrial NeoplasmsApoptosisDisease ProgressionXenograft Model Antitumor AssaysCell Line, TumorCell ProliferationMiceCo-Repressor Proteins

Keywords

Ribosome biogenesisBiologyViability assayCancer researchBiogenesisPI3K/AKT/mTOR pathwayRibosomal proteinCell biologyMolecular biologyRibosomeCellSignal transductionRNAGeneBiochemistryRapamycinEndometrial CancerMtorRibosomal BiogenesisPelp1Cell SurvivalNeoplasms. Tumors. Oncology. Including cancer and carcinogensApoptosisXenograft Model Antitumor AssaysEndometrial NeoplasmsMiceCell Line, TumorDisease ProgressionHumansAnimalsFemalePeptidesRibosomesCo-Repressor ProteinsRC254-282Research ArticleTranscription FactorsCell Proliferation

Sustainable Development Goals

SDG 0: Good health and well-being

PELP1 inhibition by SMIP34 reduces endometrial cancer progression via attenuation of ribosomal biogenesis

FAIR Checklist

Authors (17)

Funding (26 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)